Related references
Note: Only part of the references are listed.Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk
Rick A. C. M. Boonen et al.
CANCER RESEARCH (2022)
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
Sandrine M. Caputo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Functional interrogation of DNA damage response variants with base editing screens
Raquel Cuella-Martin et al.
CELL (2021)
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolarova et al.
CELLS (2020)
Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
Angeliki Delimitsou et al.
HUMAN MUTATION (2019)
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T. Parsons et al.
HUMAN MUTATION (2019)
DNA damage kinase signaling: checkpoint and repair at 30 years
Michael Charles Lanz et al.
EMBO JOURNAL (2019)
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
Amelie Rodrigue et al.
NUCLEIC ACIDS RESEARCH (2019)
Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
Rick A. C. M. Boonen et al.
NATURE COMMUNICATIONS (2019)
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Sarah E. Brnich et al.
GENOME MEDICINE (2019)
Multiplex assessment of protein variant abundance by massively parallel sequencing
Kenneth A. Matreyek et al.
NATURE GENETICS (2018)
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Jan Hauke et al.
CANCER MEDICINE (2018)
A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function
Lea M. Starita et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks
Brennan Decker et al.
JOURNAL OF MEDICAL GENETICS (2017)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou et al.
NATURE (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Melissa C. Southey et al.
JOURNAL OF MEDICAL GENETICS (2016)
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk
N. Wang et al.
ONCOGENE (2015)
Comparison of predicted and actual consequences of missense mutations
Lisa A. Miosge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Li-Fraumeni syndrome: cancer risk assessment and clinical management
Kate A. McBride et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
ClinVar: public archive of relationships among sequence variation and human phenotype
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2014)
Response to DNA damage of CHEK2 missense mutations in familial breast cancer
Wendy Roeb et al.
HUMAN MOLECULAR GENETICS (2012)
Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response
Chen Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi!Jewish men with prostate cancer
Marc D. Tischkowatz et al.
CANCER LETTERS (2008)
CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
Ranjan Chrisanthar et al.
PLOS ONE (2008)
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Daphne W. Bell et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Increased risk of breast cancer associated with CHEK2*1100delC
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair
JR Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2
JJ Li et al.
MOLECULAR CELL (2002)
Chk2 kinase - A busy messenger
J Bartek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage
XL Zhao et al.
EMBO JOURNAL (2001)
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
J Falck et al.
NATURE (2001)
Characterization of turner-associated Chk2 mutations
XL Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
